Top 200 Drugs (51-100)

Card Set Information

Author:
skylinezts
ID:
99779
Filename:
Top 200 Drugs (51-100)
Updated:
2011-09-05 14:22:24
Tags:
Top 200 Drugs 51 100
Folders:

Description:
Top 200 Drugs (51-100)
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user skylinezts on FreezingBlue Flashcards. What would you like to do?


  1. Adderall XR
    • amphetamine + dextroamphetamine
    • CNS Stimulant/ADHD
    • C-II
    • stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic)
    • BBW: high potential for abuse
    • SE: loss of appetite, xerostomia, insomnia, HA, weight loss
  2. amphetamine + dextroamphetamine
    • Adderall XR
    • CNS Stimulant/ADHD
    • C-II
    • stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic)
    • BBW: high potential for abuse
    • SE: loss of appetite, xerostomia, insomnia, HA, weight loss
  3. Detrol LA
    • tolterodine
    • Antimuscarinic
    • Urinary Antispasmodic
    • a competitive muscarinic receptor antagonist, has a high binding affinity for the cholinergic muscarinic receptors that mediates contraction of the urinary bladder, increasing the residual urine, and enhances salivation
    • SE: xerostomia, HA, constipation
  4. tolterodine
    • Detrol LA
    • Antimuscarinic
    • Urinary Antispasmodic
    • a competitive muscarinic receptor antagonist, has a high binding affinity for the cholinergic muscarinic receptors that mediates contraction of the urinary bladder, increasing the residual urine, and enhances salivation
    • SE: xerostomia, HA, constipation
  5. Vyvanse
    • lisdexamfetamine
    • CNS Stimulant/Amphetamine (class)
    • C-II
    • lisdexamfetamine dimesylate is rapidly absorbed and converted to the active drug dextroamphetamine; may block the reuptake of norepinephrine and dopamine
    • BBW: high potential for abuse
    • SE: loss of appetite, xerostomia, insomnia, HA, weight loss
  6. lisdexamfetamine
    • Vyvanse
    • CNS Stimulant/Amphetamine (class)
    • C-II
    • lisdexamfetamine dimesylate is rapidly absorbed and converted to the active drug dextroamphetamine; may block the reuptake of norepinephrine and dopamine
    • BBW: high potential for abuse
    • SE: loss of appetite, xerostomia, insomnia, HA, weight loss
  7. Toprol XL
    • metoprolol succinate
    • Beta-Adrenergic Blocker, Cardioselective
    • Cardiovascular Agent
    • a beta-adrenergic blocker with selective activity on beta(1) adrenoreceptors located mainly in cardiac muscles. At higher doses, it also inhibits beta(2) adrenoreceptors of bronchial and vascular smooth muscles.
    • BBW: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred
    • SE: dizziness, fatigue, pruritus
  8. metoprolol succinate
    • Toprol XL
    • Beta-Adrenergic Blocker, Cardioselective
    • Cardiovascular Agent
    • a beta-adrenergic blocker with selective activity on beta(1) adrenoreceptors located mainly in cardiac muscles. At higher doses, it also inhibits beta(2) adrenoreceptors of bronchial and vascular smooth muscles.
    • BBW: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred
    • SE: dizziness, fatigue, pruritus
  9. Aciphex
    • rabeprazole
    • Gastric Acid Secretion Inhibitor
    • Proton Pump Inhibitor
    • suppresses gastric acid secretion by inhibiting the gastric H+, K+-ATPase at the secretory surface of parietal cells
    • SE: abdominal pain, HA, diarrhea, N/V
  10. rabeprazole
    • Aciphex
    • Gastric Acid Secretion Inhibitor
    • Proton Pump Inhibitor
    • suppresses gastric acid secretion by inhibiting the gastric H+, K+-ATPase at the secretory surface of parietal cells
    • SE: abdominal pain, HA, diarrhea, N/V
  11. NuvaRing
    • ethinyl estradiol + etonogestrel
    • Contraceptives (vaginal insert)
    • suppression of gonadotropins to inhibit of ovulation
    • BBW: Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use.
    • SE: weight gain, sinusitis, upper resp infection
  12. ethinyl estradiol + etonogestrel
    • NuvaRing
    • Contraceptives (vaginal insert)
    • suppression of gonadotropins to inhibit of ovulation
    • BBW: Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use.
    • SE: weight gain, sinusitis, upper resp infection
  13. Flovent HFA
    • fluticasone
    • Antiasthmatic
    • Corticosteroid (intermediate), Anti-Inflammatory
    • inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects
    • SE: HA, upper resp infect, oral candidiasis
  14. fluticasone
    • Flovent HFA
    • Antiasthmatic
    • Corticosteroid (intermediate), Anti-Inflammatory
    • inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects
    • SE: HA, upper resp infect, oral candidiasis
  15. Avapro
    • irbesartan
    • Angiotensin II Receptor Antagonist (ARB)
    • Antihypertensive
    • selectively blocks the binding of angiotensin II to the AT 1 receptor
    • BBW: fetal death
    • SE: HA, fatigue
  16. irbesartan
    • Avapro
    • Angiotensin II Receptor Antagonist (ARB)
    • Antihypertensive
    • selectively blocks the binding of angiotensin II to the AT 1 receptor
    • BBW: fetal death
    • SE: HA, fatigue
  17. Combivent
    • albuterol + ipratropium
    • Bronchodilator
    • Beta-2 Agonists/Short-acting inhaled
    • combination reduces bronchospasm through both sympathomimetic and anticholinergic mechanisms. Simultaneous administration of both drugs produces a greater bronchodilator effect than when either drug is used alone at recommended dosages.
    • SE: HA, upper resp depression, bronchitis, dyspnea
  18. albuterol + ipratropium
    • Combivent
    • Bronchodilator
    • Beta-2 Agonists/Short-acting inhaled
    • combination reduces bronchospasm through both sympathomimetic and anticholinergic mechanisms. Simultaneous administration of both drugs produces a greater bronchodilator effect than when either drug is used alone at recommended dosages.
    • SE: HA, upper resp depression, bronchitis, dyspnea
  19. Boniva
    • ibandronate
    • Osteoporosis agent
    • bisphosphonates
    • inhibits osteoclast-mediated bone resorption and turnover leading to a net gain in bone mass
    • SE: upper resp infection, hypertension, indigestion, N/V
  20. ibandronate
    • Boniva
    • Osteoporosis agent
    • bisphosphonates
    • inhibits osteoclast-mediated bone resorption and turnover leading to a net gain in bone mass
    • SE: upper resp infection, hypertension, indigestion, N/V

What would you like to do?

Home > Flashcards > Print Preview